Cargando…
Role of Synucleins in Alzheimer’s Disease
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common causes of dementia and movement disorders in the elderly. While progressive accumulation of oligomeric amyloid-β protein (Aβ) has been identified as one of the central toxic events in AD leading to synaptic dysfunction, accumu...
Autores principales: | Crews, Leslie, Tsigelny, Igor, Hashimoto, Makoto, Masliah, Eliezer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727399/ https://www.ncbi.nlm.nih.gov/pubmed/19551456 http://dx.doi.org/10.1007/s12640-009-9073-6 |
Ejemplares similares
-
APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
por: Crews, Leslie, et al.
Publicado: (2009) -
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
por: Tsigelny, Igor F., et al.
Publicado: (2008) -
Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
por: Wei, Jianshe, et al.
Publicado: (2021) -
Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer’s Disease
por: Hashimoto, Makoto, et al.
Publicado: (2021) -
Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
por: Takamatsu, Yoshiki, et al.
Publicado: (2018)